A carregar...

Analysis of cabazitaxel‐resistant mechanism in human castration‐resistant prostate cancer

Cabazitaxel (CBZ) is approved for docetaxel‐resistant castration‐resistant prostate cancer (CRPC). However, efficacy of CBZ for CRPC is limited and there are no effective treatments for CBZ‐resistant CRPC. In order to investigate the CBZ‐resistant mechanism, the establishment of a CBZ‐resistant cell...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Hongo, Hiroshi, Kosaka, Takeo, Oya, Mototsugu
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125448/
https://ncbi.nlm.nih.gov/pubmed/29989268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13729
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!